Giorgio Mello

Giorgio Mello

Auto-generated profile, based on publicly available information

Giorgio Mello

Department of Gynecology, Perinatology and Human Reproduction, University of Florence, Florence, Italy

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Hypertension
Verified
Journal Article
Closed access
GMGiorgio Mello
Giorgio Mello
EPElena Parretti
Elena Parretti
CFCinzia Fatini
Cinzia Fatini
CRChiara Riviello
Chiara Riviello
FGFrancesca Gensini
Francesca Gensini
RARosanna Abbate
Rosanna Abbate
Data from literature report that angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism affects the recurrence of preeclampsia and that low-molecular-weight heparin (LMWH) prevents adverse outcomes in thrombophilic women. We investigated the effect of LMWH on the pregnancy outcome, on maternal blood pressure values, and on uteroplacental flow in ACE DD nonthrombophilic women with history of preeclampsia. Eighty nonthrombophilic ACE DD women were randomized in 2 groups: 41 treated with dalteparin 5000 IU/day and 39 untreated (control group). Women underwent 24-hour automated blood pressure monitoring in the preconceptional period and every 2 weeks from weeks 8 to 36 and transabdominal color flow/pulsed Doppler examination at weeks 16, 20, and 24. LMWH reduced the risk of clinical negative outcomes (74.1% reduction of preeclampsia and 77.5% reduction of fetal growth restriction) and the severity (88.3% reduction of early onset of preeclampsia and 86.4% reduction of early onset of fetal growth restriction). In treated women, the relative risk for preeclampsia was 0.26 ( P =0.02), and the relative risk for fetal growth restriction was 0.14 ( P <0.001). Systolic ( P =0.002) and diastolic ( P =0.002) blood pressures, as well as awake ( P =0.04) and asleep ( P =0.01) period values, and the resistance indexes of both uterine arteries ( P =0.002) were lower in the treated group. LMWH reduces the recurrence of preeclampsia, of negative outcomes, and the resistance of uteroplacental flow, and also prevents maternal blood pressure increase in ACE DD homozygote women with a previous history of preeclampsia.

1 October 2000 in Diabetes Care
Verified
Journal Article
Closed access
GMG Mello
G Mello
EPE Parretti
E Parretti
FMF Mecacci
F Mecacci
PTP La Torre
P La Torre
RCR Cioni
R Cioni
GSG Scarselli
G Scarselli
OBJECTIVE: To assess what degree of maternal metabolic control in women with type 1 diabetes is associated with normal fetal growth and results in normal neonatal body proportions in a group of full-term infants. RESEARCH DESIGN AND METHODS: We investigated the anthropometric characteristics of 98 full-term singleton infants born to 98 Caucasian women with type 1 diabetes enrolled within 12 weeks of gestation. The type 1 diabetic mother-infant pairs were divided into three groups on the basis of the daily glucose levels reached during the second and third trimesters of pregnancy (group 1: 37 mother-infant pairs with an average daily glucose level during the second and third trimesters of < or =95 mg/dl; group 2: 37 mother-infant pairs with an average daily glucose level during the second trimester of >95 mg/dl and during the third trimester of < or =95 mg/dl; group 3: 24 mother-infant pairs with an average daily glucose level during the second and third trimesters of >95 mg/dl; control group: 1,415 Caucasian mother-infant pairs with full-term singleton pregnancies and normal glucose challenge test screened for gestational diabetes. RESULTS: Infants of diabetic mothers in group 1 were similar to those of the control group in birth weight and in other anthropometric parameters. In contrast, offspring of diabetic mothers of groups 2 and 3 showed an increased incidence of large-for-gestational-age infants, significantly greater means of ponderal index and thoracic circumferences, and significantly smaller cranial/thoracic circumference ratios with respect to the control group. CONCLUSIONS: The results of our study suggest that, in diabetic pregnancies, only overall daily glucose values < or =95 mg/dl throughout the second and third trimesters can avoid alterations in fetal growth.

1 April 2003 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
GMGiorgio Mello
Giorgio Mello
EPElena Parretti
Elena Parretti
RCRiccardo Cioni
Riccardo Cioni
RLRoberto Lucchetti
Roberto Lucchetti
LCLucia Carignani
Lucia Carignani
MPMonica Pratesi
Monica Pratesi
OBJECTIVE—To investigate, in pregnant women without gestational diabetes mellitus (GDM), the relation among obstetric/demographic characteristics; fasting, 1-h, and 2-h plasma glucose values resulting from a 75-g glucose load; and the risk of abnormal neonatal anthropometric features and then to verify the presence of a threshold glucose value for a 75-g glucose load above which there is an increased risk for abnormal neonatal anthropometric characteristics. RESEARCH DESIGN AND METHODS—The study group consisted of 829 Caucasian pregnant women with singleton pregnancy who had no history of pregestational diabetes or GDM, who were tested for GDM with a 75-g, 2-h glucose load, used as a glucose challenge test, in two periods of pregnancy (early, 16–20 weeks; late, 26–30 weeks), and who did not meet the criteria for a GDM diagnosis. In the newborns, the following abnormal anthropometric characteristics were considered as outcome measures: cranial/thoracic circumference (CC/TC) ratio ≤10th percentile for gestational age (GA), ponderal index (birth weight/length3 × 100) ≥90th percentile for GA, and macrosomia (birth weight ≥90th percentile for GA), on the basis of growth standard development for our population. For the first part of the objective, logistic regression models were used to identify 75-g glucose load values as well as obstetric and demographic variables as markers for abnormal neonatal anthropometric characteristics. For the second part, the receiver operating characteristic (ROC) curve was performed for the 75-g glucose load values to determine the plasma glucose threshold value that yielded the highest combined sensitivity and specificity for the prediction of abnormal neonatal anthropometric characteristics. RESULTS—In both early and late periods, maternal age >35 years was a predictor of neonatal CC/TC ratio ≤10th percentile and macrosomia, with fasting 75-g glucose load values being independent predictors of neonatal CC/TC ratio ≤10th percentile. In both periods, 1-h values gave a strong association with all abnormal neonatal anthropometric characteristics chosen as outcome measures, with maternal age >35 years being an independent predictor for macrosomia. The 2-h, 75-g glucose load values were significantly associated in both periods with neonatal CC/TC ratio ≤10th percentile and ponderal index ≥90th percentile, whereas maternal age >35 years was an independent predictor of both neonatal CC/TC ratio ≤10th percentile and macrosomia. In the ROC curves for the prediction of neonatal CC/TC ratio ≤10th percentile for GA in both early and late periods of pregnancy, inflection points were identified for a 1-h, 75-g glucose load threshold value of 150 mg/dl in the early period and 160 mg/dl in the late period. CONCLUSIONS—This study documented a significant association, seen even in the early period of pregnancy, between 1-h, 75-g glucose load values and abnormal neonatal anthropometric features, and provided evidence of a threshold relation between 75-g glucose load results and clinical outcome. Our results would therefore suggest the possibility of using a 75-g, 1-h oral glucose load as a single test for the diagnosis of GDM, adopting a threshold value of 150 mg/dl at 16–20 weeks and 160 mg/dl at 26–30 weeks.

31 July 2003 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
EPE. Parretti
E. Parretti
FMF. Mealli
F. Mealli
AMA. Magrini
A. Magrini
RCR. Cioni
R. Cioni
FMF. Mecacci
F. Mecacci
GMG. Mello
G. Mello

1 April 2001 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
RBRiccarda Del Bene
Riccarda Del Bene
GBGiuseppe Barletta
Giuseppe Barletta
GMGiorgio Mello
Giorgio Mello
CLChiara Lazzeri
Chiara Lazzeri
FMFederico Mecacci
Federico Mecacci
GVGiorgio La Villa
Giorgio La Villa

17 December 2014
Verified
Journal Article
Closed access
SSSerena Simeone
Serena Simeone
CSCaterina Serena
Caterina Serena
MRMarianna P Rambaldi
Marianna P Rambaldi
LMLaura Marchi
Laura Marchi
GMGiorgio Mello
Giorgio Mello
FMFederico Mecacci
Federico Mecacci